The gut microbiota modifies antibody durability and booster responses after SARS-CoV-2 vaccination
The findings of this study underscored the potential interaction between the gut microbiome and the longevity/boosting effect of antibodies following vaccination against SARS-CoV-2. The identification of specific microbial associations suggests the prospect of microbiome-based strategies for enhancing vaccine efficacy.
Authors
- Hee Jin Cheong (ORCID: https://orcid.org/0000-0002-2532-1463)
- Eliel Nham (ORCID: https://orcid.org/0000-0001-7509-4863)
- Jin Gu Yoon (ORCID: https://orcid.org/0000-0003-3283-1880)
- Eui Ho Kim (ORCID: https://orcid.org/0000-0002-4235-5622)
- Hye Seong (ORCID: https://orcid.org/0000-0002-5633-7214)
- Joon Young Song (ORCID: https://orcid.org/0000-0002-0148-7194)
- Ji Yun Noh (ORCID: https://orcid.org/0000-0001-8541-5704)
- Woo Joo Kim (ORCID: https://orcid.org/0000-0002-4546-3880)
- Chulwoo Kim (ORCID: https://orcid.org/0000-0001-5736-8170)
- Sooyeon Lim (ORCID: https://orcid.org/0000-0002-5589-1299)
- Young-Hee Han
- Yu Jung Choi
Institutions
- International Vaccine Institute (KR)
- Institut Pasteur Korea (KR)
- Chungbuk National University (KR)
- Korea University (KR)
- Korea University Medical Center (KR)
- Korea University (JP)
Publication Details
- Journal
- Journal of Translational Medicine
- Published
- 2024-09-06
- DOI
- https://doi.org/10.1186/s12967-024-05637-2
- Citations
- 8
- Primary Topic
- Clostridium difficile and Clostridium perfringens research
- Type
- article
- Field-Weighted Citation Impact
- 3.11
Funders
- National Research Foundation
- Ministry of Education
- Ministry of Science and ICT, South Korea
- Korea Centers for Disease Control and Prevention